Vanguard Group’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $36.8M | Buy |
|
|||||
|
2024
Q3 | $10.5M | Buy |
|
|||||
|
2024
Q2 | $9.94M | Buy |
|
|||||
|
2024
Q1 | $10.8M | Buy |
|
|||||
|
2023
Q4 | $9.74M | Buy |
|
|||||
|
2023
Q3 | $6.28M | Buy |
|
|||||
|
2023
Q2 | $4.56M | Buy |
|
|||||
|
2023
Q1 | $7.27M | Buy |
|
|||||
|
2022
Q4 | $12.4M | Sell |
|
|||||
|
2022
Q3 | $8.42M | Buy |
|
|||||
|
2022
Q2 | $3.42M | Sell |
|
|||||
|
2022
Q1 | $6.48M | Sell |
|
|||||
|
2021
Q4 | $9.89M | Sell |
|
|||||
|
2021
Q3 | $11M | Buy |
|
|||||
|
2021
Q2 | $13.3M | Sell |
|
|||||
|
2021
Q1 | $13.7M | Buy |
|
|||||
|
2020
Q4 | $6.45M | Buy |
|
|||||
|
2020
Q3 | $5.03M | Buy |
|